PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 270 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $228,920 | -3.0% | 5,713 | -1.2% | 0.00% | – |
| Q1 2023 | $235,963 | -6.7% | 5,782 | +21.8% | 0.00% | -100.0% |
| Q3 2022 | $253,000 | +10.0% | 4,749 | +20.6% | 0.00% | 0.0% |
| Q2 2022 | $230,000 | -32.2% | 3,939 | -11.3% | 0.00% | 0.0% |
| Q1 2022 | $339,000 | +48.7% | 4,439 | +18.1% | 0.00% | – |
| Q2 2021 | $228,000 | -38.7% | 3,759 | -29.1% | 0.00% | -100.0% |
| Q1 2021 | $372,000 | +52.5% | 5,303 | +30.0% | 0.00% | 0.0% |
| Q4 2020 | $244,000 | -7.2% | 4,079 | -6.9% | 0.00% | 0.0% |
| Q3 2020 | $263,000 | -22.9% | 4,382 | -32.5% | 0.00% | 0.0% |
| Q2 2020 | $341,000 | +48.3% | 6,490 | -5.2% | 0.00% | 0.0% |
| Q1 2020 | $230,000 | -14.8% | 6,847 | +14.8% | 0.00% | 0.0% |
| Q4 2019 | $270,000 | +15.9% | 5,963 | +11.2% | 0.00% | 0.0% |
| Q2 2019 | $233,000 | -3.3% | 5,361 | -4.3% | 0.00% | 0.0% |
| Q4 2018 | $241,000 | -1.6% | 5,602 | +12.2% | 0.00% | 0.0% |
| Q3 2018 | $245,000 | – | 4,992 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Doma Perpetual Capital Management LLC | 1,000,761 | $28,631,772 | 13.28% |
| GAGNON SECURITIES LLC | 596,591 | $17,068,469 | 3.84% |
| Sio Capital Management, LLC | 455,500 | $13,031,855 | 3.53% |
| Gagnon Advisors, LLC | 133,390 | $3,816,288 | 2.91% |
| AlphaCentric Advisors LLC | 117,500 | $3,361,675 | 2.48% |
| ARDSLEY ADVISORY PARTNERS LP | 580,000 | $16,593,800 | 2.44% |
| RICE HALL JAMES & ASSOCIATES, LLC | 998,625 | $28,570,661 | 1.71% |
| Lisanti Capital Growth, LLC | 138,830 | $3,971,926 | 0.96% |
| Bridge City Capital, LLC | 84,856 | $2,427,730 | 0.82% |
| Rock Springs Capital Management LP | 785,000 | $22,458,850 | 0.68% |